THURSDAY, June 23, 2022 (HealthDay News) — To ensure that all kinds of patients get drugs and devices that are safe and effective for them, they need to be represented in clinical trials, but a new study shows that representation of women in key disease areas continues to lag. ResearchersContinue Reading
WEDNESDAY, June 22, 2022 (HealthDay News) — Could your smartwatch know you have a COVID infection before you do? It might be possible one day. New research suggests that wearable activity trackers that monitor the changes in your skin temperature, heart and breathing rates, combined with artificial intelligence, could beContinue Reading
MONDAY, June 20, 2022 (HealthDay News) — Patients who have spinal anesthesia while doctors repair a broken hip have more pain and need more prescription painkillers afterward than those given general anesthesia, a new study finds. Spinal anesthesia is increasingly used as a way to reduce pain and painkiller use,Continue Reading
FRIDAY, June 17, 2022 (HealthDay News) — An experimental Alzheimer’s drug called crenezumab did not prevent or slow mental decline in patients with a genetic mutation that greatly raises the risk of developing the disease, the results of a decade-long clinical trial show. The mutation seen in the few hundredContinue Reading
THURSDAY, June 16, 2022 (HealthDay News) — Researchers have figured out a way to safely give children a donor kidney without the need for immune-suppressing drugs — an advance they hope to expand to many more kidney transplant patients in coming years. Reporting in the June 15 issue of theContinue Reading
THURSDAY, June 16, 2022 (HealthDay News) — Treating precancerous anal growths in people with HIV slashes their risk of anal cancer by more than half, according to a new study. Researchers found that treating these growths — called high-grade squamous intraepithelial lesions (HSIL) — is a safe and effective wayContinue Reading
WEDNESDAY, June 15, 2022 (HealthDay News) — Cancer clinical trials in the United States appear to be rebounding after a significant slowdown during the pandemic, researchers say. For the study, the investigators analyzed data from the Dana-Farber Cancer Institute in Boston and the Tisch Cancer Institute at Mount Sinai MedicalContinue Reading
MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading
FRIDAY, June 10, 2022 (HealthDay News) — A requirement for all international travelers flying to the United States to take a COVID-19 test within a day of departure will be lifted on Sunday, a senior Biden administration official said Friday. The U.S. Centers for Disease Control and Prevention has determinedContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — A blood test could save some colon cancer patients from getting unnecessary chemotherapy following surgery, while making sure that those who would benefit from the treatment get it, researchers report. The circulating tumor DNA (ctDNA) test looks for minute amounts of genetic materialContinue Reading